The latest precision medicine news

Genome Insight Launches in the U.S. with Innovative Whole Genome Sequencing Approach that Offers Unprecedented, Actionable Insights in Cancer Care

–CancerVision designed to democratize fast, affordable cancer analysis and diagnosis with broadened access to complete genomic information– –Company opened San Diego-based corporate...read more

Broad Institute Launches $1K Sample-to-Report Clinical Whole-Genome Sequencing Service

As clinical whole-genome sequencing (WGS) is becoming more of a routine diagnostic test for certain patients with genetic disorders, the Broad Institute has launched a new end-to-end WGS and variant interpretation...read more

Velsera Is Building an Ecosystem that Accelerates the R&D Loop and Democratizes Omics Data to Propel the Next Era of Precision Medicine

My most recent interview is with Gavin Nichols, the CEO of the newly formed company Velsera. Velsera launched in January 2023, after quietly acquiring the three companies Seven Bridges, UgenTec, and Pierian in mid...read more

The Cheap Genome Is Not Enough – We Need an “Accurate and Good Genome”

We may still be five Years out until We Can Sequence Everyone I had the chance to attend the Precision Medicine World Conference PMWC 2023 SV in the last couple of days. Some 2,000+ individuals from across the life...read more

Goodbye 2022 – Hello 2023

We say goodbye to 2022 which was full of significant developments in the life sciences, precision medicine, genetics, and genomics sectors. Notable new players in the next-generation sequencing field showcased their...read more

ONTOFORCE Wants to Increase Data Literacy and Empower Citizen Data Scientists

This month’s “Company Spotlight” provides a closer look at ONTOFORCE, the creator of a semantic search technology platform for insight generation. I spoke with Valerie Morel, CEO of ONTOFORCE, about ONTOFORCE’s platform...read more

UK GENOMICS SPOTLIGHT Report: LEADING INNOVATIONS 2022

Published by the UK Department for International Trade (DIT) in partnership with the ABHI (Association British HealthTech Industries), BIA (BioIndustry Association), Genomics England, and the NHS England and NHS...read more

Time Is What We Want Most – Why Wasting Any More of It?

As many of us continuously experience, combing through the latest news in any scientific research area or a given commercial sector – whether it is to stay up-to-date in a specific field, view the latest trends in...read more

Deepcell Aims to Create a Single Cell Morpholome Platform

This month’s “Company Spotlight” takes a closer look at Deepcell, a company that is building a platform for the identification, isolation, and classification of viable cells based on their morphological distinctions for...read more

We Invite you to join enlightenbio’s Subject Matter Expert Network!

enlightenbio is a boutique consultancy providing product strategy and market intelligence to precision medicine industries. Our mission is to help our clients successfully develop, launch, and market exceptional...read more

Truwl is on a Mission to Make Bioinformatics Comprehensible and Accessible

This latest interview is with Karl Sebby, the CEO of Truwl. Truwl is an exciting, relatively new bioinformatics company that engages in accelerating and simplifying biological research. Truwl is also the name of the...read more

Genomenon Raises $20M Series B Financing, Launching a New Era in AI-Powered Genomic Data

Financing led by Beringea and Spring Mountain Capital to fuel continued growth in pharmaceutical and clinical diagnostic markets Genomenon®Inc., an AI-driven genomics company, today announced the completion of a...read more

Enlightenbio Releases New Report – Database of Biomarkers Curated from US Oncology Trials

Palo Alto, CA, January 21, 2022 – The “Database of Biomarkers Curated from Oncology Trials” report has been added to the enlightenbio LLC product offering. This new report provides insights into...read more

2021, The Year of the Various SARS-CoV-2 Variants of Concern – from Alpha to Omicron

A review of the various SARS-CoV-2 Omicron mutations 2021 was the year of multiple variants of concerns (VOCs) starting with the Alpha variant in the UK, which was first detected in November 2020, and spread quickly by...read more

2021 – Precision Medicine linked with Genomic Medicine: A Work in Progress

2021 – A True Testimony that we Sit at The Intersection of Significant New Opportunities The significant opportunities at the intersection of biology, technology, and big data and the advancements resulting from...read more

Patient-Centric Rare Disease Genome Maps Join The Web

For far too long, rare disease patients and their guardians have had to wait “forever” for genetic information to be returned back to them. All of that is about to change: thanks to the convergence of mapping...read more

Singular Genomics Launches the G4 Sequencing Platform

Next-generation sequencing platform will provide up to three times more data output per hour than other benchtop instruments, while offering flexible run capacity – December 16, 2021 07:30 ET |...read more

Rebus Bio Continues Expansion of Industry-leading Spatial Omics Platform with Breakthrough High-Plex Technology

EEL assay overcomes well-known limitations in spatial biology SANTA CLARA, Calif. & STOCKHOLM–(BUSINESS WIRE)–Rebus Biosystems Inc, (“Rebus Bio”, “Rebus”), an Illumina Ventures-backed life science...read more

PacBio and UCLA Health Announce Research Collaboration for Whole Genome Sequencing in Rare Diseases

Collaboration aims to identify variants not easily detectible by short-read sequencing, increasing diagnostic yield in rare disease patients MENLO PARK, Calif., Dec. 07, 2021 (GLOBE NEWSWIRE) — PacBio (Nasdaq:...read more

Bionano Genomics Acquiring BioDiscovery – The Perfect Alignment of the Stars

One of October’s headlines in the field of genomics and genetics included the acquisition of BioDiscovery by Bionano Genomics. I spoke with Soheil Shams, President, Founder, and CSO of BioDiscovery and now Chief...read more

Illumina and Genetic Alliance Launch $120 Million Global Initiative to Increase Equity and Improve Outcomes for Families Impacted by Genetic Disease

The iHope™ Genetic Health program will expand access to whole-genome sequencing to low- and middle-income communities around the world, with more than one-third of funds being allocated to patients in Africa SAN DIEGO...read more

Color announces Series E financing, at a valuation of $4.6 billion, to accelerate expansion of accessible and equitable public health infrastructure

With an additional $100 million in funding, Color will use the infrastructure built during the pandemic to increase access to essential healthcare services to screen, diagnose, and treat populations where they are SAN...read more

Armonica Technologies Closes B Round Financing

ALBUQUERQUE, N.M., Oct. 18, 2021 /PRNewswire/ — Armonica Technologies, Inc., a biotechnology company developing a high throughput, direct long-read DNA sequencing technology, announced that it has...read more

Mayo Clinic collaborates with Personalis Inc. to expand cancer genomic testing

ROCHESTER, Minn., and MENLO PARK, Calif. — Mayo Clinic announced an agreement on Tuesday, Oct. 12 that will allow it to offer clinical-grade comprehensive cancer genomic sequencing to cancer patients who choose to...read more

Bionano Genomics to Acquire BioDiscovery, Furthering Bionano’s Vision of Creating the Most Comprehensive Variant Analysis Platform in Genomics

Designed to accelerate the adoption of optical genome mapping (OGM) with the integration of BioDiscovery’s N x Clinical software solution for variant analysis Adds a world-class team, software and bioinformatics...read more

Our Top Selection of Precision Medicine News

Precision medicine, omics, and genetics news from around the world.